CytoMed Therapeutics Limited (GDTC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for CytoMed Therapeutics Limited, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.94
+5.06% today
Market cap
$11M
Overall quality
46/100
Kronos AI 30-day
—
CytoMed Therapeutics Limited (GDTC) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $11M. It trades at $0.94, up 5.06% today. Its overall quality score is 46 out of 100, ranked against the whole US market. 1 analysts' average target of $4.16 implies +342.6% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $4.16 |
| Low – high | $4.16 – $4.16 |
| Analysts | 1 |
| Upside to average | +342.6% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 11 |
| Solvency | 85 |
| Growth | 42 |
| Overall | 46 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.